Innovations in label-free detection technologies, increasing drug discovery programs through research partnerships between pharmaceutical companies and academic institutes, and growth in the global pharmaceutical and biotechnology industries are factors driving the growth of this market. On the other hand, the high cost of instruments is likely to restrain the market growth to a certain extent.
The report "Label-Free Detection Market by Technology (Surface Plasmon Resonance, Bio-layer Interferometry), Products (Consumables, Microplates, Biosensor Chips), Applications (Binding Kinetics, Thermodynamics, Lead Generation), End User - Global Forecast to 2022", The global label-free detection market is expected to reach USD 1,311.2 Million by 2022 from USD 872.2 Million in 2017, at a CAGR of 8.5%.
Browse 110 Market Data Tables and 39 Figures spread through 147 Pages and in-depth TOC on "Label-Free Detection Market"
Instruments are estimated to dominate the market in 2017
On the basis of product, the label-free detection market is segmented into instruments and consumables. The instruments segment is expected to dominate the global label-free detection market in 2017.
Advantages of label-free detection technique in studying bio-molecular interactions and increasing inclination towards employing biosensor enabled detection of biomolecules in drug discovery and research are the key drivers for the growth of this segment.
The surface plasmon resonance segment is estimated to command the largest market share in 2017
The label-free detection market is segmented by technology into surface plasmon resonance, bio-layer interferometry, isothermal titration calorimetry, differential scanning calorimetry, and other technologies. In 2017, the surface plasmon resonance is expected to account for the largest share of the label-free detection market, by technology.
The large share of this segment can primarily be attributed to the increasing need for studying biomolecular interaction analysis in drug discovery processes and the increasing demand for biosensors in the digitalization of drug manufacturing processes.
North America expected to account for the largest share of the market in 2017
Based on region, the label-free detection market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the label-free detection market in 2017.
The large share of North America is attributed to increasing drug discovery and development research activities and public and private funding for label-free detection in this region.
Key players in the label-free detection market include General Electric (US), Danaher (US), PerkinElmer (US), AMETEK (US), Roche (Switzerland), Corning (US), Hitachi (Japan), HORIBA (Japan), Shimadzu (Japan), TA Instruments. (US), Mettler-Toledo (US), Spectris (Malvern PANalytical) (UK), BiOptix (US), Wyatt Technology (UK), ACEA BIO (US), Attana (Sweden), NanoTemper Technologies (Germany), Affinité Instrument (Canada), Nicoya Lifesciences (Canada), Applied Photophysics (UK), Biosensing Instrument (US), Unchained Labs.
(US), BioNavis (Finland), Insplorion (Sweden), and LUMICKS (Netherlands).
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...
For more information: